We confirmed the expressions of ALK, MET, and ROS1 mRNA (receptor tyrosine kinases that serve as therapeutic targets in non-small-cell lung cancers [19,28]), in the mouse retina (Fig 3). This evidence concerns the gene ROS1 and non-small cell lung carcinoma.